Early Type 2 Diabetes conversations survey launched

The International Diabetes Federation is very pleased to announce the launch of the largest multinational survey to investigate early conversations between physicians and people living with Type 2 Diabetes (T2D).
This survey, led by Boehringer Ingelheim and Eli Lilly and Company, was developed in partnership with the International Diabetes Federation (IDF) and will include more than 10,000 people with T2D and more than 6,500 treating-physicians across 26 countries worldwide.
It will help to optimise the early conversations between patients and physicians and advance the quality of diabetes care worldwide.
You can download the press release here.